Compile Data Set for Download or QSAR
Report error Found 523 of affinity data for UniProtKB/TrEMBL: Q92831
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748527(US20250188030, Compound E3)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748427(US20250188030, Compound C7)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748435(US20250188030, Compound C16)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748423(US20250188030, Compound C3)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748405(US20250188030, Compound B20)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748458(US20250188030, Compound C40)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748440(US20250188030, Compound C21)
Affinity DataKi:  0.110nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748387(US20250188030, Compound B2)
Affinity DataKi:  0.130nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748424(US20250188030, Compound C4)
Affinity DataKi:  0.140nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748389(US20250188030, Compound B4)
Affinity DataKi:  0.150nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748429(US20250188030, Compound C9)
Affinity DataKi:  0.170nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748425(US20250188030, Compound C5)
Affinity DataKi:  0.180nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748413(US20250188030, Compound B28)
Affinity DataKi:  0.190nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748528(US20250188030, Compound E4)
Affinity DataKi:  0.210nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748443(US20250188030, Compound C24)
Affinity DataKi:  0.220nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748437(US20250188030, Compound C18)
Affinity DataKi:  0.310nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748398(US20250188030, Compound B13)
Affinity DataKi:  0.350nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748525(US20250188030, Compound E1)
Affinity DataKi:  0.380nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748580(US20250188030, Compound J7)
Affinity DataKi:  0.460nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748448(US20250188030, Compound C29)
Affinity DataKi:  0.470nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748583(US20250188030, Compound J10)
Affinity DataKi:  0.490nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748446(US20250188030, Compound C27)
Affinity DataKi:  0.530nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748444(US20250188030, Compound C25)
Affinity DataKi:  0.550nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748592(US20250188030, Compound K3)
Affinity DataKi:  0.560nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748586(US20250188030, Compound J13)
Affinity DataKi:  0.620nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748574(US20250188030, Compound J1)
Affinity DataKi:  0.740nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748438(US20250188030, Compound C19)
Affinity DataKi:  0.800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748431(US20250188030, Compound C12)
Affinity DataKi:  0.930nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748593(US20250188030, Compound K4)
Affinity DataKi:  0.940nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50539801(CHEMBL4648912 | US11840533, Compound 70)
Affinity DataKd: <1nMAssay Description:Binding affinity to human partial length PCAF (G715 to D831 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748351(US20250188030, Compound A6)
Affinity DataKi:  1.21nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50234923(CHEMBL4069412)
Affinity DataKi:  1.26nMAssay Description:Binding affinity to human partial length PCAF bromodomain expressed in mammalian expression system by BROMOscan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2019
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50234923(CHEMBL4069412)
Affinity DataKi:  1.30nMAssay Description:Binding affinity to human partial length PCAF bromodomain expressed in mammalian expression system by BROMOscan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2019
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748361(US20250188030, Compound A16)
Affinity DataKi:  2.43nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748346(US20250188030, Compound A1)
Affinity DataKi:  2.65nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748368(US20250188030, Compound A23)
Affinity DataKi:  2.85nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748433(US20250188030, Compound C14)
Affinity DataKi:  5.62nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748515(US20250188030, Compound D7)
Affinity DataKi:  6.44nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50512964(CHEMBL4574669)
Affinity DataIC50: 7nMAssay Description:Inhibition of biotinylated peptide binding to human GST-tagged PCAF bromodomain expressed in Escherichia coli Rosetta (DE3) measured after 15 hrs by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50512976(CHEMBL4543497)
Affinity DataIC50: 10nMAssay Description:Inhibition of biotinylated peptide binding to human GST-tagged PCAF bromodomain expressed in Escherichia coli Rosetta (DE3) measured after 15 hrs by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50573197(CHEMBL4872300)
Affinity DataKd:  12nMAssay Description:Binding affinity to PCAF (unknown origin) by BROMOscan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50234932(CHEMBL4103402 | US10239861, Example 20)
Affinity DataIC50: 12.7nMAssay Description:His/Flag epitope tagged PCAF719-832 bromodomain was cloned, expressed and purified to homogeneity in-house. PCAF bromodomain binding and inhibition o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50234932(CHEMBL4103402 | US10239861, Example 20)
Affinity DataIC50: 13nMAssay Description:Inhibition of biotinylated ligand binding to FLAG epitope-fused/His-tagged PCAF bromodomain (719 to 832 residues) (unknown origin) measured after 15 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50234932(CHEMBL4103402 | US10239861, Example 20)
Affinity DataIC50: 13nMAssay Description:Displacement of biotinylated small molecule ligand from His/FLAG-tagged PCAF bromodomain (719 to 832 residues) (unknown origin) after 15 mins by Alph...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2019
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50573200(CHEMBL4861491)
Affinity DataKd:  14nMAssay Description:Binding affinity to PCAF (unknown origin) by BROMOscan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50512967(CHEMBL4449143)
Affinity DataIC50: 14nMAssay Description:Inhibition of biotinylated peptide binding to human GST-tagged PCAF bromodomain expressed in Escherichia coli Rosetta (DE3) measured after 15 hrs by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM748426(US20250188030, Compound C6)
Affinity DataKi:  14.8nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM50512958(CHEMBL4439202)
Affinity DataIC50: 17nMAssay Description:Inhibition of biotinylated peptide binding to human GST-tagged PCAF bromodomain expressed in Escherichia coli Rosetta (DE3) measured after 15 hrs by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM311486(US10155764, Example 65B | CHEM-US-00192)
Affinity DataIC50: 19nMAssay Description:Inhibition of biotinylated ligand binding to FLAG epitope-fused/His-tagged PCAF bromodomain (719 to 832 residues) (unknown origin) measured after 15 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase KAT2B(Human)
Pfizer

US Patent
LigandPNGBDBM311486(US10155764, Example 65B | CHEM-US-00192)
Affinity DataIC50: 19nMAssay Description:Displacement of biotinylated small molecule ligand from His/FLAG-tagged PCAF bromodomain (719 to 832 residues) (unknown origin) after 15 mins by Alph...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2019
Entry Details Article
PubMed
Displayed 1 to 50 (of 523 total ) | Next | Last >>
Jump to: